Terms: = Lymphoma AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020 AND Treatment
4 results:
1. A rapid genotyping panel for detection of primary central nervous system lymphoma.
Gupta M; Burns EJ; Georgantas NZ; Thierauf J; Nayyar N; Gordon A; Jones SS; Pisapia M; Sun Y; Burns RP; Velarde J; Jordan JT; Frigault MJ; Nahed BV; Jones PS; Barker FG; Curry WT; Gupta R; Batchelor TT; Romero JM; Brastianos PK; Marble HD; Martinez-Lage M; Tateishi K; Lennerz JK; Dietrich J; Cahill DP; Carter BS; Shankar GM
Blood; 2021 Aug; 138(5):382-386. PubMed ID: 33735913
[TBL] [Abstract] [Full Text] [Related]
2. Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.
Moskowitz CH; Walewski J; Nademanee A; Masszi T; Agura E; Holowiecki J; Abidi MH; Chen AI; Stiff P; Viviani S; Bachanova V; Sureda A; McClendon T; Lee C; Lisano J; Sweetenham J
Blood; 2018 Dec; 132(25):2639-2642. PubMed ID: 30266774
[TBL] [Abstract] [Full Text] [Related]
3. Three case reports of radiation-induced glioblastoma after complete remission of acute lymphoblastic leukemia.
Kajitani T; Kanamori M; Saito R; Watanabe Y; Suzuki H; Watanabe M; Kure S; Tominaga T
Brain Tumor Pathol; 2018 Apr; 35(2):114-122. PubMed ID: 29666969
[TBL] [Abstract] [Full Text] [Related]
4. Early mortality in bone marrow transplantation for acute lymphocytic leukaemia a multivariate analysis of risk factors.
Algara M; Valls A; Marrugat J; Grañena A
Eur J Med; 1993; 2(7):386-92. PubMed ID: 8258025
[TBL] [Abstract] [Full Text] [Related]
